×

Mast cell stabilizers treatment for systemic disorders

  • US 9,962,363 B2
  • Filed: 02/09/2015
  • Issued: 05/08/2018
  • Est. Priority Date: 02/10/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method of administering a therapeutically effective amount of cromolyn sodium to a patient in need thereof, comprising administering to said patient an aqueous pharmaceutical composition consisting of (i) from about 2% to about 6% by weight of cromolyn sodium and (ii) an osmolarity adjusting agent consisting of (A) between about 0.1% and about 0.5% by weight of sodium chloride, inclusive of the endpoints, and (B) optionally salts of EDTA, wherein said pharmaceutical composition is administered to said patient by inhalation into the lungs in the form of an aerosol exhibiting a respirable fraction (≤

  • 5 μ

    m) as measured by USP <

    1601>

    of at least about 60%.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×